Biotech · Private company
Biocon Limited
Track this companyFree. Adds Biocon Limited to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- EQ001Phase 2 · Acute-graft-versus-host DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Itolizumab [Bmab 600]Phase 1 · Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)PHASE3 · TERMINATED · started Apr 29, 2022ClinicalTrials.gov NCT05263999 · fetched Nov 12, 2026
- Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative NephritisPHASE1 · COMPLETED · started Oct 1, 2019ClinicalTrials.gov NCT04128579 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHDPHASE1_PHASE2 · COMPLETED · started Jul 15, 2019ClinicalTrials.gov NCT03763318 · fetched Nov 12, 2026